|
|
|
HPV Clinical Trials |
|
Thank you for your interest in clinical trials for HPV
Please click "Search" to find HPV clinical trials and medical research studies.
If you receive too many study listings you may enter your zip code to find the locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
Your Search Returned No Results. |
|
|
|
|
|
Results from other databases:
|
|
|
|
Your search returned 98 studies:
- Acceptance of Human Papillomavirus Vaccination in Postpartum Women - NCT00730704-10032
Conditions: Human Papilloma Virus - HPV - Post Partum
Location: New York, NY
- Alternate Dosing Schedules Study for HPV Vaccine - NCT00862810-27704A
Conditions: Cervical Cancer - Genital Warts
Location: Durham, NC
- Alternate Dosing Schedules Study for HPV Vaccine - NCT00862810-27704B
Conditions: Cervical Cancer - Genital Warts
Location: Durham, NC
- Alternate Dosing Schedules Study for HPV Vaccine - NCT00862810-27704C
Conditions: Cervical Cancer - Genital Warts
Location: Durham, NC
- Extended Follow-Up of Young Women in Costa Rica Who Received Vaccination Against Human Papillomavirus Types 16 and 18 and Unvaccinated Controls - NCT00867464-20892
Conditions: Cervical Neoplasia - HPV Infections
Location: Bethesda, MD
- Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females - NCT00813319-30303
Conditions: Vaccination
Location: Atlanta, GA
- Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects - NCT00937950-16508
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections - Cervical Neoplasia
Location: Erie, PA
- Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects - NCT00937950-27514
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections - Cervical Neoplasia
Location: Chapel Hill, NC
- HPV Infections in Older Women - NCT00743392-98103
Conditions: Papillomavirus Infections
Location: Seattle, WA
- Human Papilloma Virus (HPV) Vaccination Commitment and Compliance Among Rural African American Primary Caregivers and Their Daughters - NCT00937287-30602
Conditions: HPV
Location: Athens, GA
- Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer - NCT00435214-94612
Conditions: Cervical Cancer - Cervical Precancer
Location: Oakland, CA
- Human Papillomavirus (HPV) Infection in Pregnancy - NCT00194311-19104
Conditions: Papillomavirus Infections - Pregnancy Complications
Location: Philadelphia, PA
- Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta - NCT00443313-
Conditions: Uterine Cervical Cancer
Location: Jackson, MS
- Human Papillomavirus (HPV) Vaccination Acceptance by African-American Parents: Identifying Psychosocial Barriers - NCT00680147-13244
Conditions: HPV
Location: Syracuse, NY
- Impact of an HPV Vaccine in HIV-Infected Young Women - NCT00710593-10128
Conditions: HIV Infection
Location: New York, NY
- Impact of an HPV Vaccine in HIV-Infected Young Women - NCT00710593-10467
Conditions: HIV Infection
Location: Bronx, NY
- Impact of an HPV Vaccine in HIV-Infected Young Women - NCT00710593-19104
Conditions: HIV Infection
Location: Philadelphia, PA
- Impact of an HPV Vaccine in HIV-Infected Young Women - NCT00710593-20010
Conditions: HIV Infection
Location: Washington, DC
- Impact of an HPV Vaccine in HIV-Infected Young Women - NCT00710593-21201
Conditions: HIV Infection
Location: Baltimore, MD
- Impact of an HPV Vaccine in HIV-Infected Young Women - NCT00710593-33101
Conditions: HIV Infection
Location: Miami, FL
- Impact of an HPV Vaccine in HIV-Infected Young Women - NCT00710593-33316
Conditions: HIV Infection
Location: Fort Lauderdale, FL
- Impact of an HPV Vaccine in HIV-Infected Young Women - NCT00710593-33606
Conditions: HIV Infection
Location: Tampa, FL
- Impact of an HPV Vaccine in HIV-Infected Young Women - NCT00710593-38105
Conditions: HIV Infection
Location: Memphis, TN
- Impact of an HPV Vaccine in HIV-Infected Young Women - NCT00710593-60612
Conditions: HIV Infection
Location: Chicago, IL
- Impact of an HPV Vaccine in HIV-Infected Young Women - NCT00710593-60614
Conditions: HIV Infection
Location: Chicago, IL
- Impact of an HPV Vaccine in HIV-Infected Young Women - NCT00710593-70112
Conditions: HIV Infection
Location: New Orleans, LA
- Impact of an HPV Vaccine in HIV-Infected Young Women - NCT00710593-90027
Conditions: HIV Infection
Location: Los Angeles, CA
- Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3 - NCT00685412-15445
Conditions: Papillomavirus Infections
Location: Hopwood, PA
- Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3 - NCT00685412-19104
Conditions: Papillomavirus Infections
Location: Philadelphia, PA
- Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3 - NCT00685412-27103
Conditions: Papillomavirus Infections
Location: Winston-Salem, NC
- Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men - NCT00666107-90822
Conditions: Anal Cancer - HIV Infections
Location: Long Beach, CA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Newark, NJ
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-02114
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Boston, MA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-02115
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Boston, MA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-02906
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Providence, RI
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-10016
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: New York, NY
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-10461
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: New York, NY
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-11794
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Stony Brook, NY
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-14642A
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Rochester, NY
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-14642B
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Rochester, NY
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-19104
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Philadelphia, PA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-20006
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Washington, DC
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-21201
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Baltimore, MD
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-23219
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Richmond, VA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-27401
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Greensboro, NC
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-30308
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Atlanta, GA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-32209
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Jacksonville, FL
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-33136
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Miami, FL
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-35924
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Birmingham, AL
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-37203
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Nashville, TN
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-38105
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Memphis, TN
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-44106
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Cleveland, OH
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-60611
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Chicago, IL
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-60614
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Chicago, IL
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-63108
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: St. Louis, MO
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-70112
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: New Orleans, LA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-77030
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Houston, TX
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-90033A
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Los Angeles, CA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-90033B
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Los Angeles, CA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-90095
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Los Angeles, CA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-90806
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Long Beach, CA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-92103
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: San Diego, CA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-94110
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: San Francisco, CA
- Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women - NCT00604175-94305
Conditions: HIV Infections - Sexually Transmitted Diseases
Location: Stanford, CA
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-07962
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Morristown, NJ
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-10029
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: New York, NY
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-12601
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Poughkeepsie, NY
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-15106
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Carnegie, PA
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-16502
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Erie, PA
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-16508
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Erie, PA
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-19107
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Philadelphia, PA
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-19114
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Philadelphia, PA
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-22903
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Charlottesville, VA
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-27514
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Chapel Hill, NC
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-28562
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: New Bern, NC
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-33409
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: West Palm Beach, FL
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-33759
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Clearwater, FL
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-40202
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Louisville, KY
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-52242
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Iowa City, IA
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-55455
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Minneapolis, MN
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-67005
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Arkansas City, KS
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-67114
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Newton, KS
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-67207
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Wichita, KS
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-68131
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Omaha, NE
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-74105
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Tulsa, OK
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-77030
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Houston, TX
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-77598
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Webster, TX
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-78705
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Austin, TX
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-80027
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Louisville, CO
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-80218
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Denver, CO
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-87131
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Albuquerque, NM
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-92108
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: San Diego, CA
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-97210
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Portland, OR
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US - NCT00799825-98801
Conditions: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Location: Wenatchee, WA
- The Human Papillomavirus (HPV) Transmission Pilot Study - NCT00823511-33612
Conditions: Human Papillomavirus Infection
Location: Tampa, FL
- Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3) - NCT00988559-21205
Conditions: HPV16+ - Cervical Intraepithelial Neoplasia (CIN 2/3)
Location: Baltimore, MD
- Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3) - NCT00988559-21224
Conditions: HPV16+ - Cervical Intraepithelial Neoplasia (CIN 2/3)
Location: Baltimore, MD
- Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3) - NCT00988559-35294
Conditions: HPV16+ - Cervical Intraepithelial Neoplasia (CIN 2/3)
Location: Birmingham, AL
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|